Last reviewed 2026-04-19 · How we verify
Home › Drugs › Jiangsu HengRui Medicine Co., Ltd. › SHR7280 dry suspension SHR7280 dry suspension
SHR7280 is a dry suspension under development by Jiangsu HengRui Medicine Co., Ltd. It has completed a Phase 1 trial assessing its relative bioavailability compared to tablets. No FDA label is available.
At a glance
Generic name SHR7280 dry suspension Sponsor Jiangsu HengRui Medicine Co., Ltd. Modality Small molecule Phase Phase 1
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.
Not medical advice. Information on this page is collated from primary regulatory and clinical-trial sources for research purposes. It is not a substitute for consultation with a licensed healthcare professional. See our editorial policy for sourcing and methodology.